BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8780549)

  • 1. Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Stanus E; Brotchi J; Hildebrand J
    Cancer; 1996 Sep; 78(5):1098-106. PubMed ID: 8780549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First year experience using the Fischer ZD-Neurosurgical Localizing Unit with particular reference to the development of PET-guided stereotactic biopsy.
    Levivier M; Goldman S; Pirotte B; Brotchi J
    Acta Neurol Belg; 1993; 93(1):5-22. PubMed ID: 8451917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
    Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
    J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
    Tsuyuguchi N
    Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.
    Walker C; du Plessis DG; Fildes D; Haylock B; Husband D; Jenkinson MD; Joyce KA; Broome J; Kopitski K; Prosser J; Smith T; Vinjamuri S; Warnke PC
    Clin Cancer Res; 2004 Nov; 10(21):7182-91. PubMed ID: 15534091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.
    Pirotte B; Goldman S; Bidaut LM; Luxen A; Stanus E; Brucher JM; Balériaux D; Brotchi J; Levivier M
    Acta Neurochir (Wien); 1995; 134(1-2):79-82. PubMed ID: 7668134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography elucidates transport system and tumor proliferation in meningiomas.
    Murakami M; Imahori Y; Kimura S; Tatsuzawa K; Ohwada K; Inoue Y; Sasajima H; Mineura K
    Oncol Rep; 2005 Oct; 14(4):853-9. PubMed ID: 16142342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of pathology and survival by FDG PET in gliomas.
    Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
    J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas.
    Jain R; Narang J; Gutierrez J; Schultz LR; Scarpace L; Rosenblum M; Mikkelsen T; Rock JP
    Acad Radiol; 2011 Aug; 18(8):955-62. PubMed ID: 21718954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.
    Hara T; Kondo T; Hara T; Kosaka N
    J Neurosurg; 2003 Sep; 99(3):474-9. PubMed ID: 12959432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study.
    Herholz K; Pietrzyk U; Voges J; Schröder R; Halber M; Treuer H; Sturm V; Heiss WD
    J Neurosurg; 1993 Dec; 79(6):853-8. PubMed ID: 8246053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients.
    Pirotte BJ; Levivier M; Goldman S; Massager N; Wikler D; Dewitte O; Bruneau M; Rorive S; David P; Brotchi J
    Neurosurgery; 2009 Mar; 64(3):471-81; discussion 481. PubMed ID: 19240609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose.
    Levivier M; Goldman S; Pirotte B; Brucher JM; Balériaux D; Luxen A; Hildebrand J; Brotchi J
    J Neurosurg; 1995 Mar; 82(3):445-52. PubMed ID: 7861223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma.
    Sadeghi N; Salmon I; Decaestecker C; Levivier M; Metens T; Wikler D; Denolin V; Rorive S; Massager N; Baleriaux D; Goldman S
    AJNR Am J Neuroradiol; 2007 Mar; 28(3):455-61. PubMed ID: 17353312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
    De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
    Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas: a stereotactic PET and MRI study.
    Mertens K; Acou M; Van Hauwe J; De Ruyck I; Van den Broecke C; Kalala JP; D'Asseler Y; Goethals I
    Clin Nucl Med; 2013 Jul; 38(7):495-500. PubMed ID: 23640217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET as a prognostic factor in high-grade astrocytoma.
    De Witte O; Lefranc F; Levivier M; Salmon I; Brotchi J; Goldman S
    J Neurooncol; 2000 Sep; 49(2):157-63. PubMed ID: 11206011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic significance of regional blood flow, blood volume, oxygen extraction fraction, and metabolic rates of oxygen and glucose as measured by positron emission tomography in patients with gliomas].
    Mineura K; Suda Y; Sasajima T; Yasuda T; Kowada M; Ogawa T; Shishido F; Uemura K
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2556-62. PubMed ID: 2614191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.